These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12533165)

  • 1. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A.
    Heckmann M; Teichmann B; Pause BM; Plewig G
    Arch Dermatol; 2003 Jan; 139(1):57-9. PubMed ID: 12533165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
    Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
    Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making scents: improvement of olfactory profile after botulinum toxin-A treatment in healthy individuals.
    Heckmann M; Kütt S; Dittmar S; Hamm H
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S81-7. PubMed ID: 17241419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
    Schnider P; Binder M; Kittler H; Birner P; Starkel D; Wolff K; Auff E
    Br J Dermatol; 1999 Apr; 140(4):677-80. PubMed ID: 10233320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis.
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    J Am Acad Dermatol; 1999 Dec; 41(6):987-90. PubMed ID: 10570385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin--a possible new treatment for axillary hyperhidrosis.
    Bushara KO; Park DM; Jones JC; Schutta HS
    Clin Exp Dermatol; 1996 Jul; 21(4):276-8. PubMed ID: 8959898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Axillary hyperhidrosis: successful treatment with botulinum toxin A].
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    Hautarzt; 1998 Feb; 49(2):101-3. PubMed ID: 9551330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T; Konrad H; Karte K; Wollina U
    Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin, sweating, and body odor.
    Bushara MA; Bushara K
    N Engl J Med; 2002 Aug; 347(8):620-1; author reply 620-1. PubMed ID: 12192029
    [No Abstract]   [Full Text] [Related]  

  • 14. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A.
    He J; Wang T; Dong J
    J Dermatolog Treat; 2012 Dec; 23(6):461-4. PubMed ID: 21801111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
    Wollina U; Karamfilov T; Konrad H
    J Am Acad Dermatol; 2002 Apr; 46(4):536-40. PubMed ID: 11907503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical effects of botulinum toxin A and microwave thermolysis for axillary hyperhidrosis: A descriptive study with line-field confocal optical coherence tomography and histology.
    Grove GL; Jacobsen K; Maartensson NL; Haedersdal M
    Exp Dermatol; 2024 Jun; 33(6):e15110. PubMed ID: 38884423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.